Get all your news in one place.
100's of premium titles.
One app.
Start reading
Fortune
Fortune
Lindsey Leake

Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs

A person stands on a scale. (Credit: COURTESY OF HIMS & HERS)

It’s no secret that weight-loss medications, particularly those of the injectable variety, are in high demand. Without insurance, they’re also costly. Wegovy (semaglutide) has a list price of $1,349.02 for a four-week supply. Competitor Zepbound (tirzepatide) is a smidge cheaper at $1,086.37. And as these drugs are FDA-approved for chronic weight management, they’re meant to be taken indefinitely. Even if your insurance covers the bulk of the expenses, you may have to jump through prior authorization hoops.

Telehealth company Hims & Hers has had enough—and is putting its money where its mouth is in the form of its first Super Bowl ad, called “Sick of the System.” The minute-long commercial is abrasive, even chaotic, which is presumably the point. Set to Childish Gambino’s “This Is America,” a takedown of gun violence and systemic racism, the third-quarter big game slot, in no uncertain terms, accuses the pharmaceutical industry of price-gouging weight-loss drugs, thereby fueling the obesity crisis.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.